Meg Hooton

R&D

Meg Hooton, President of IQVIA Biotech, leads the organisation, providing clinical development solutions for biotech and emerging biopharma clients.

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.